From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents
- DOI
- 10.1016/j.ejcped.2025.100304
- Published
- 2025-12
- Container
- EJC Paediatric Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejcped.2025.100304,
title = {From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents},
author = {Sarah K. Tasian and Judith M. Boer and Monique L. den Boer},
year = {2025},
journal = {EJC Paediatric Oncology},
doi = {10.1016/j.ejcped.2025.100304},
url = {https://doi.org/10.1016/j.ejcped.2025.100304}
}RIS
TY - JOUR TI - From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents AU - Sarah K. Tasian AU - Judith M. Boer AU - Monique L. den Boer PY - 2025 JO - EJC Paediatric Oncology DO - 10.1016/j.ejcped.2025.100304 UR - https://doi.org/10.1016/j.ejcped.2025.100304 ER -
APA
Tasian, S. K., Boer, J. M., & Boer, M. L. D. (2025). From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents. EJC Paediatric Oncology. https://doi.org/10.1016/j.ejcped.2025.100304
Source records
- crossref · retrieved 2026-09-26T03:22:16.460Z